For instance, exon sequencing has revealed SPOP mutations in up to 13% of prostate cancers, where these mutations rank first among all altered genes and compromise substrate-binding capacity and oligomerization with SPOP [30]. The gene discussed is SPOP; the disease is prostate carcinoma.